Amendment: SEC Form SC 13G/A filed by QuidelOrtho Corporation
$QDEL
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
5/8/2025 | $44.00 | Hold → Buy | Jefferies |
12/11/2024 | $44.00 → $50.00 | Neutral → Buy | Citigroup |
12/10/2024 | $43.00 | Hold | Jefferies |
9/19/2024 | $42.00 → $50.00 | Neutral | UBS |
9/5/2024 | $40.00 → $57.00 | Hold → Buy | Craig Hallum |
3/4/2024 | $70.00 → $42.00 | Neutral → Sell | UBS |
2/14/2024 | $66.00 → $37.00 | Neutral → Underweight | JP Morgan |
12/11/2023 | $95.00 → $72.00 | Buy → Neutral | Citigroup |